is synthroid safe

The short version: Synthroid (levothyroxine) is a replacement for a missing hormone, not a drug that adds a new chemical. The evidence here shows it corrects lab values and improves symptoms, but the long-term safety data is thin and mostly from studies with no true placebo group.

The evidence in front of me comes from a mix of sources. The 2005 bone-density study [9] was published in a journal that does not disclose funding, but it compared 88 women on long-term suppressive levothyroxine to 88 matched healthy controls and found no difference in bone mineral density at the femoral neck. The 2012 cohort study [1] found "little evidence of adverse effects on bone health" but also reported that bone turnover markers changed in ways that are hard to interpret without a control group. The 2017 geriatric study [6] is a before-after design with no control group at all—it measured ECG changes after treatment, but you cannot separate the drug effect from natural recovery or regression to the mean. The pregnancy meta-analysis [3] shows that untreated subclinical hypothyroidism roughly doubles the risk of pregnancy loss (relative risk 2.01) and neonatal death (2.58), and that levothyroxine treatment brought those risks back to baseline [8]. That is a real benefit for a specific population.

What is missing matters more than what is here. None of these studies compare levothyroxine to a true placebo in a randomized trial with all-cause mortality or serious adverse events as the primary endpoint. The longest follow-up is the 2005 bone study [9], which matched patients to controls but did not randomize. The 2012 cohort [1] followed patients for a limited time and measured surrogate markers (bone density, grip strength) rather than fractures or falls. The 2017 geriatric study [6] lasted only three months. No study here tracks what happens to people who take levothyroxine for decades, which is the real question for most patients.

The mechanism is straightforward: levothyroxine is synthetic T4, identical to the hormone your thyroid makes. When your thyroid does not produce enough, replacing it restores normal metabolism. The risk comes from over-replacement—too much T4 can cause atrial fibrillation, bone loss, and anxiety. The evidence here shows that when dosing is monitored by TSH, those risks appear manageable. The 2005 study [9] found that even suppressive doses (TSH around 0.03) did not cause bone loss in premenopausal women, though postmenopausal women showed a trend toward lower lumbar bone density that did not reach statistical significance.

My call: for people with confirmed hypothyroidism who are monitored with regular TSH testing, levothyroxine is likely safe and clearly beneficial. The evidence is strongest for pregnant women, where untreated hypothyroidism carries real risks [3, 8]. The evidence is weakest for long-term use in older adults, where no study has tracked hard outcomes like fractures, heart rhythm problems, or death over decades. Confidence: moderate.